CINDY HINH: Open Payments
NPI 1396462628 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 14 payments from 10 companies in 2025. Trend: 2023 $279 · 2024 $480 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $91 |
| SOBI, INC | 2 | $72 |
| TerSera Therapeutics LLC | 1 | $38 |
| Incyte Corporation | 2 | $36 |
| Aveo Pharmaceuticals, Inc. | 1 | $35 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $33 |
| Eisai Inc. | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $30 |
Products named: KEYTRUDA, Vonjo, Xermelo, JAKAFI, FOTIVDA, ENJAYMO, CALQUENCE, Lenvima.
Industry payments across LA — which companies pay providers there.
